Oxidative stress and inflammatory markers in streptozotocin-induced acute and subacute toxicity response
Ebru Şancı,Çinel Köksal Karayıldırım,Melih Dağdeviren,Gürkan Yiğittürk,Aylin Buhur,Oytun Erbaş,Altuğ Yavaşoğlu,Nefise Ülkü Karabay Yavaşoğlu
DOI: https://doi.org/10.1080/01480545.2024.2315150
2024-02-14
Drug and Chemical Toxicology
Abstract:Streptozotocin (STZ) is used as a diabetes-inducing agent in experimental animal studies. However, it is known that STZ-induced diabetic animals show significant increases in oxidative stress parameters and neurodegeneration besides their blood glucose level. In this study, the acute and subacute toxic effects of STZ on the liver, sciatic nerve, and brain tissues were investigated in vivo rat model. Sprague-Dawley rats were divided into two groups; while 50 mg/kg STZ was administered ip to the STZ group, only saline was administered to the control group. After STZ administration, three units (100 U/mL) of subcutaneous insulin glargine were applied daily to prevent the formation of diabetes. At 24 h, 1,2, and 4 weeks after applications, rats from each group were sacrificed and tissues were removed under anesthesia. At the end of the study, compared to the control, a significant decrease in SOD and GST activity and an increase in lipid peroxidation were detected in the liver and sciatic tissues of rats in the STZ-treated group in the first 24h. Considering the TUNEL, NFκB, and NOS2 expressions, it was noted that while the effects of STZ on the liver were observed in the acute stage (24h), it had subacute effects on the brain. When apoptosis-related gene expression ( Bcl-2, Bax, CASP3, CASP8, CASP9, TNF-α ) and immunohistochemistry were evaluated, the apoptotic effect of STZ was observed mostly in sciatic nerve tissues. Within the scope of the study, it was revealed that STZ did not only show selective toxicity to pancreatic β cells but also very toxic to other tissues and organs.
pharmacology & pharmacy,toxicology,chemistry, multidisciplinary